Jasper Therapeutics (JSPR) Misses Q3 EPS by 113c

Jasper Therapeutics (NASDAQ: JSPR) reported Q3 EPS of ($1.13).

For earnings history and earnings-related data on Jasper Therapeutics (JSPR) click here.

You May Also Be Interested In

• Reports Of Blasts Across Iran's Southern Regions: State TV - Bloomberg
• Energy Vault’s 100 MW AI Infrastructure Project in Sardinia Receives Italian Government Designation as Project of Pre-Eminent National Strategic Interest
• Putin, Xi, Trump may hold trilateral talks at APEC summit - Russia's Vesti